Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Timber Pharmaceuticals, Inc. (TMBR)

Pharmaceutical Preparations

https://www.timberpharma.com

Timber Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its investigational therapies have mechanisms of action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. The company is focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), X-linked recessive CI (XLRI) and autosomal recessive CI (ARCI), and other sclerotic skin diseases. The company's late-stage program is TMB-001., and TMB-003 is the earliest-stage program.

3 MOUNTAINVIEW ROAD, SUITE 100
WARREN, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/19/2020

Market Cap

1,176,057

Shares Outstanding

3,430,000

Weighted SO

3,432,735

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

SLRX --.--%

ARTLW --.--%

NTRB --.--%

ALRN --.--%

ARTL --.--%

HSTO --.--%

CRIS --.--%

FWBI --.--%

SABS --.--%

Beta

-0.6540

Last Div

0.0000

Range

0.32-3.39

Chg

0.0025

Avg Vol

107900

Mkt Cap

1176057

Exch

AMEX

Country

US

Phone

973 314 9577

DCF Diff

0.3818

DCF

2.5318

Div Yield

0.0000

P/S

14.1392

EV Multiple

0.0563

P/FV

-0.4027

Div Yield %

0.0000

P/E

-0.0702

PEG

-0.0023

Payout

0.0000

Current Ratio

0.4962

Quick Ratio

0.4480

Cash Ratio

0.4480

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

68.2288

CCC

-68.2288

Gross Margin

-103.9385

Op Margin

-176.6421

Pretax Margin

-179.4614

Net Margin

-180.9074

Eff Tax Rate

-0.0124

ROA

-4.5239

ROE

-5.2078

ROCE

6.3928

NI/EBT

1.0081

EBT/EBIT

1.0160

EBIT/Rev

-176.6421

Debt Ratio

0.1639

D/E

-0.2080

LT Debt/Cap

-0.1404

Total Debt/Cap

-0.2626

Int Coverage

-56.4658

CF/Debt

-25.4711

Equity Multi

-1.2690

Rec Turnover

0.0000

Pay Turnover

5.3496

Inv Turnover

0.0000

FA Turnover

0.2133

Asset Turnover

0.0250

OCF/Share

-4.5065

FCF/Share

-4.5075

Cash/Share

0.8177

OCF/Sales

-166.9334

FCF/OCF

1.0002

CF Coverage

-25.4711

ST Coverage

-62.4506

CapEx Coverage

-4483.3781

Div&CapEx Cov

-4483.3781

P/BV

-0.4027

P/B

-0.4027

P/S

14.1392

P/E

-0.0702

P/FCF

-0.0847

P/OCF

-0.0760

P/CF

-0.0760

PEG

-0.0023

P/S

14.1392

EV Multiple

0.0563

P/FV

-0.4027

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 29, 17:26 Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market GlobeNewswire Inc. Nov 29, 17:26 Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market GlobeNewswire Inc. Nov 28, 17:21 Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American GlobeNewswire Inc. Nov 28, 17:21 Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

Revenue Product Segmentation